In Brazil Veterinary Medicine Market, offering valuable insights, key market trends, competitive landscape, and future outlook to support strategic decision.

Between 2014 and 2023, revenue of the veterinary market in Brazil increased by approximately *** percent. In 2023, revenue of the industry stood at nearly ** billion Brazilian reals, up from **** billion Brazilian reals recorded a year earlier.

This statistic shows the revenue of the industry “Manufacture of medicines for veterinary use“ in Brazil from 2011 to 2017, with a forecast to 2023. It is projected that the revenue of Manufacture of medicines for veterinary use in Brazil will amount to approximately ******* million U.S. Dollars by 2023.

In 2024, the Brazilian veterinary medicine vaccines market decreased by -4.6% to $464M for the first time since 2019, thus ending a four-year rising trend. Overall, the total consumption indicated a slight expansion from 2012 to 2024: its value increased at an average annual rate of +1.4% over the last twelve-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period.

Brazil Animal Health Market was valued at USD 2.59 Billion in 2024 and is expected to reach USD 4.25 Billion in the forecast period with a CAGR of 8.56% through 2030.

The Brazil Veterinary Service Market was valued at more than USD 4 billion in 2022.

Brazil Veterinary-Animal Vaccines Market is expanding as animal disease outbreaks become more frequent, and the focus on animal welfare and public health intensifies.

The Brazil Veterinary Vaccines Market size was valued at USD 10.38 million in 2023 and is projected to reach USD 18.45 million by 2032, exhibiting a CAGR of 6.4 % during the forecasts period. It refers to the process of manufacturing, marketing and supply of vaccines in the Brazil for the treatment of animal ailments. As discussed these vaccines are crucial for livestock, poultry, pets, aquaculture to ensure the well-being of animals to prevent the spreading of zoonosis. Some of applications are involved in commercial production of crops and animal husbandry, pet shops, vet shops and clinics. Stringent trends triggering this market embrace development of the livestock farming, more demand for animals for companionship, and enhanced concern towards animal well being. Also, there is a tendency for strange vaccines like recombinant and DNA vaccines and even there is a concentration on producing animal vaccines through government support to safeguard the food chain.

Brazil Veterinary Vaccines Market was valued at USD 1.45 Billion in 2024 and is expected to reach USD 2.48 Billion in the forecast period with a CAGR of 9.36% through 2030.

In Brazil Companion Animal Drugs Market, offering valuable insights, key market trends, competitive landscape, and future outlook to support strategic decision-making and business growth.

Brazil Wholesale Trade: CNAE 2.0: Pharmaceutical, Medical, Orthopaedic, Dental & Veterinary: Marketing Margin Rate data was reported at 56.100 % in 2017. This records a decrease from the previous number of 56.600 % for 2016. Brazil Wholesale Trade: CNAE 2.0: Pharmaceutical, Medical, Orthopaedic, Dental & Veterinary: Marketing Margin Rate data is updated yearly, averaging 57.000 % from Dec 2007 (Median) to 2017, with 11 observations. The data reached an all-time high of 62.300 % in 2013 and a record low of 50.300 % in 2007. Brazil Wholesale Trade: CNAE 2.0: Pharmaceutical, Medical, Orthopaedic, Dental & Veterinary: Marketing Margin Rate data remains active status in CEIC and is reported by Brazilian Institute of Geography and Statistics. The data is categorized under Brazil Premium Database’s Wholesale Trade, Retail Trade, Repair of Automotive and Motorcycles Sector – Table BR.RJB010: Wholesale Trade: Financial Data: CNAE 2.0: Pharmaceutical, Medical, Orthopaedic, Dental and Veterinary.

Snapshot img

Companion Animal Specialty Drugs Market Size 2025-2029

The companion animal specialty drugs market size is forecast to increase by USD 6.54 billion at a CAGR of 7.4% between 2024 and 2029.

The market is experiencing significant growth due to the increasing trend of pet humanization, which has led to an increased demand for specialized veterinary medications. Pet owners are treating their animals as family members and are willing to invest in their health and wellbeing, driving the market's expansion. Furthermore, the development of innovative companion animal specialty drug offerings is catering to the unique needs of pets, providing effective solutions for various health conditions. However, the market faces challenges as well. The patent expiry of several companion animal specialty drugs poses a threat to market players, as generic alternatives enter the market and price competition intensifies.
This could impact the profitability of companies and necessitate a focus on research and development to maintain a competitive edge. Additionally, regulatory requirements and stringent approval processes can prolong the time-to-market for new specialty drugs, increasing the risk and cost of bringing new products to market. Companies must navigate these challenges effectively by investing in research and development, building strategic partnerships, and adhering to regulatory guidelines to capitalize on the market's growth opportunities.

What will be the Size of the Companion Animal Specialty Drugs Market during the forecast period?

Request Free Sample

How is this Companion Animal Specialty Drugs Industry segmented?

The companion animal specialty drugs industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Distribution Channel

  Veterinary hospitals
  Pet care clinics
  Pharmacy stores


Product

  Vaccines
  Antibiotics
  Parasiticides
  Feed additives
  Others


Route Of Administration

  Oral
  Injectable


Animal Type

  Cats
  Dogs
  Horses
  Others


Drug Type

  Anti-Infectives
  Anti-Inflammatories
  Vaccines


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  Middle East and Africa

    Egypt
    KSA
    Oman
    UAE


  APAC

    China
    India
    Japan


  South America

    Argentina
    Brazil


  Rest of World (ROW)

By Distribution Channel Insights

The veterinary hospitals segment is estimated to witness significant growth during the forecast period.

In the realm of veterinary care, the companion animal sector encompasses a significant market segment. Veterinary pharmaceuticals play a pivotal role in this industry, supplying essential medications for pets. Veterinary technicians, an integral part of the animal healthcare team, ensure the effective administration of these drugs. Pet owners prioritize their beloved companions' health and safety, driving the demand for high-quality veterinary services. Data analytics and electronic medical records facilitate personalized treatments, enabling veterinary professionals to provide precise care. Wearable devices and mobile apps offer real-time monitoring, enhancing preventive care. Supply chain management ensures the timely distribution of veterinary drugs, maintaining the continuity of care.

Advancements in veterinary science include gene therapy, artificial intelligence, and Diagnostic Imaging, revolutionizing the treatment of chronic diseases. Research institutions and veterinary specialists collaborate on clinical trials to develop new drugs and therapies, addressing the needs of aging pets and various animal health concerns. Regulatory compliance is crucial in the veterinary pharmaceutical industry, ensuring the safety and efficacy of prescription drugs. Over-the-counter medications cater to common ailments, while veterinary education and continuing professional development keep animal care professionals updated on the latest treatments and technologies. Animal shelters and animal hospitals rely on veterinary software and cloud computing for efficient record-keeping and data management.

Affordable care initiatives and pet insurance help ensure access to essential treatments for pets. Drug interactions and adverse effects necessitate careful consideration, with regulatory approvals and quality control measures in place to safeguard animal welfare. Neurological, cardiovascular, and Oncology Drugs, among others, offer innovative solutions for pets with complex health issues. Veterinary informatics and data privacy are essential aspects of modern veterinary practice, enabling predictive analytics and precision medicine. The veterinary community's ongoing research and development drive advancements in veterinary care, ulti

Brazil Imports: FOB: Transformation Industry: Medicines and Pharmaceutical Products, Except Veterinary data was reported at 814,277.299 USD th in 30 Apr 2025. This records an increase from the previous number of 704,225.922 USD th for 27 Apr 2025. Brazil Imports: FOB: Transformation Industry: Medicines and Pharmaceutical Products, Except Veterinary data is updated daily, averaging 340,763.585 USD th from May 2019 (Median) to 30 Apr 2025, with 254 observations. The data reached an all-time high of 1,025,206.681 USD th in 30 Sep 2021 and a record low of 30,119.111 USD th in 05 Jul 2020. Brazil Imports: FOB: Transformation Industry: Medicines and Pharmaceutical Products, Except Veterinary data remains active status in CEIC and is reported by Special Secretariat for Foreign Trade and International Affairs. The data is categorized under Brazil Premium Database’s Foreign Trade – Table BR.JAA008: Imports: Economic Activity: Product: Value.

The size of the Brazil Veterinary Artificial Insemination Market was valued at USD 1.17 billion in 2023 and is projected to reach USD 2.10 billion by 2032, with an expected CAGR of 8.75 % during the forecast period. The veterinary artificial insemination (AI) market in Brazil is expanding very fast because of the strong agriculture sector of Brazil, especially in the field of livestock farming. The country ranks among the top in terms of beef and poultry production worldwide. Artificial insemination, thus, plays a significant role in the improvement of livestock genetics, enhancement of reproductive efficiency, and higher productivity. Farmers are adopting AI as a cost-effective and efficient method of breeding high-quality animals, leading to healthier herds and better quality meat and milk. The growth of the market is further augmented by the developments in AI technologies, including better semen preservation methods and better fertility techniques. Moreover, government policies on animal husbandry and modern farming practices have led to an increase in this market. As Brazil further solidifies its position as a world leader in agriculture, the veterinary AI market is likely to increase with technological advancements and the demand for more sustainable and profitable farming practices. Recent developments include: In June 2024, Pon Holding announced the sale of their majority stake in Brazil’s leading veterinary AI company, Urus Group, to CVC for over Euro 600 Mn (USD 641.9 Mn) , In March 2024, researchers from Brazil and the US successfully bred a cow through artificial insemination and produced insulin in its milk. This can prove to be very beneficial to individuals suffering from diabetes, as insulin milk acquired from such cows can be directly ingested by them to eliminate the need to administer an injection. , In 2024, researchers from the Federal University of Minas Gerais (Brazil) collaborated with PIC UK to analyze over 1,500 boars using artificial intelligence to explore ways to improve their semen quality. The technology tests the anatomical structures as well as the semen of the boar and predicts the samples that have a lesser AI success rate. , In November 2023, Semex Brazil merged its AI center, Tairana, with Cenatte, a leading embryo facility in Brazil, to enhance its artificial insemination products & service portfolio. , In November 2023, the Brazilian government signed an agreement with the Cuban government for the export of dairy, beef, pork, poultry & seafood products. .

Brazil’s telecom market will grow over 4.88% CAGR through 2030, with increased investment in broadband and fiber network expansion.

This statistic shows the sales volume of antibiotics for animal feed production in Brazil in 2013 as well as a forecast thereof for 2030. In 2030, the forecasted sales of antibiotics for animal feed production in Brazil is expected to reach over nine thousand metric tons.

In Brazil Animal Health Market, offering valuable insights, key market trends, competitive landscape, and future outlook to support strategic decision-making and business growth.

This statistic shows the revenue of the industry “Furniture for medical, dental, or veterinary use (dental chairs, surgical tables, etc.)“ in Brazil from 2014 to 2018, with a forecast to 2025. It is projected that the revenue of Furniture for medical, dental, or veterinary use (dental chairs, surgical tables, etc.) in Brazil will amount to approximately ****** million U.S. Dollars by 2025.

Brazil Animal Model Market was valued at USD 0.095 billion in 2024 and is projected to reach USD 0.194 billion by 2032, growing at a CAGR of 9.3% from 2026 to 2032.Brazil Animal Model Market Drivers and TrendsAccording to Verified Market Research, the following drivers and trends are shaping the Brazil Animal Model Market:Government support for biotechnology sector development - Brazil's National Biotechnology Policy and programs like FINEP (Innovation Financing Agency) provide substantial funding for life sciences research, creating sustained demand for animal models in academic and industrial researchGrowing pharmaceutical manufacturing and R&D capabilities - Brazil's position as Latin America's largest pharmaceutical market, with domestic companies like EMS and Cristália expanding R&D operations, is driving demand for animal models for drug development and regulatory compliance

In 2022, distribution channels such as pet shops and veterinary clinics accounted for **** percent of the total establishments in the pet market in Brazil. Meanwhile, pet breeding establishments represented **** percent of the share. In that same year, revenue of the pet industry in Brazil reached a value of **** billion Brazilian reals.